Berberine and milk thistle are two well-studied botanical compounds that are sometimes combined for complementary metabolic and liver support. Research suggests that berberine, an alkaloid found in plants like goldenseal and barberry, may help support healthy blood sugar levels and cholesterol profiles by activating AMP-activated protein kinase, a key enzyme in metabolic regulation. Studies indicate that milk thistle's active compound, silymarin, has antioxidant and hepatoprotective properties that may support liver function and help the body process lipids more efficiently. When paired together, preliminary research points to a potentially synergistic relationship, where milk thistle may enhance berberine's bioavailability while both compounds contribute to broader metabolic wellness, though more large-scale clinical trials are needed to fully establish the benefits of this combination.
Compare this supplementResearch suggests that both berberine and milk thistle (silymarin) have been studied individually in the context of m...
View studies →Research suggests that the available published evidence specifically examining berberine and milk thistle as a combin...
View studies →These are commonly referenced dosage ranges for this supplement. They are not medical recommendations. Always consult a healthcare provider before supplementing.
| Form | Dose range | Frequency | Studied for | Source |
|---|---|---|---|---|
| Capsule | 500 mg | Three times daily | Blood sugar regulation and insulin sensitivity | Berberine 500mg TID is the most replicated dose in RCTs for glycemic control; milk thistle co-administered for hepatoprotection |
| Capsule | 300–500 mg | Twice daily | Cholesterol management and lipid profile improvement | Common in clinical trials combining berberine with silymarin for dyslipidemia |
| Capsule | 140–200 mg | Twice daily | Liver health and hepatoprotection | Silymarin component dose range observed in combination product RCTs targeting NAFLD and liver enzyme normalization |
| Capsule | 500–600 mg | Daily | Metabolism support and weight management | Lower combined daily doses studied in metabolic syndrome trials with fixed-dose berberine-silymarin formulations |
| Tablet | 500 mg | Twice daily | Type 2 diabetes and non-alcoholic fatty liver disease (NAFLD) | Berberine 1000mg/day with silymarin 280mg/day studied in Italian multicenter trials for NAFLD with metabolic comorbidities |